OliX Pharmaceuticals, Inc (KOSDAQ:226950)
77,300
-5,100 (-6.19%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 1.76T -34.6% |
| Revenue (ttm) | 13.64B +80.9% |
| Net Income | -14.03B |
| EPS | -662.93 |
| Shares Out | 22.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 64,287 |
| Open | 80,400 |
| Previous Close | 82,400 |
| Day's Range | 77,100 - 80,600 |
| 52-Week Range | 69,100 - 217,000 |
| Beta | 0.44 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 16, 2027 |